Medlab Clinical Limited (MDC) - Research

$0.370
Prices as at 15:36, 25 Apr 2019

MDC Current Share Price+

Current Price $0.370
Open $0.365
High $0.370
Low $0.365
Last Close $0.370
Volume 50546
Price Movement - ( No change )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

MDC General Information

Medlab Clinical Limited
MDC
http://www.medlab.co
Biotechnology
78
211

MDC Company Overview

Business Description

Medlab Clinical Limited (MDC) is a medical life science company, developing therapeutic pathways for diagnosed chronic diseases. It is advanced in developing therapies for pain management, depression and obesity as well as earning revenue from sale of nutritional products in Australia and the United States. In pain management Medlab is developing cannabis-based medicines.

MDC Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2018 A -4.76 -2.40 0.00% 0.00 0.00 0.00% 0.0%
2017 A -3.84 -2.10 0.00% 0.00 0.00 0.00% 0.0%
2016 A -3.72 -2.10 0.00% 0.00 0.00 0.00% 0.0%

MDC Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2016 A 2017 A 2018 A 2016 A 2017 A 2018 A 2016 A 2017 A 2018 A
CSL (CSL) $86,257M 0.3775 0.1257 0.1290 36.2679 32.2170 28.5348 1.62% 1.42% 1.63%
Clinuvel Pharmaceuticals (CUV) $1,089M 0.8671 0.0000 0.0000 83.3333 0.0000 0.0000 0.09% 0.00% 0.00%
Medlab Clinical (MDC) $80M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Mesoblast (MSB) $780M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Polynovo (PNV) $612M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

MDC Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 3.36 0.00
Market 0.71 14.90 1.20 1.08
Sector 1.02 24.40 3.31 2.83

MDC Directors

Name Position Start Date
Mr Sean Michael Hall Chief Executive Officer, Managing Director 17 Apr 2014
Mr Michael Jack Hall Non-Executive Chairman, Non-Executive Director 17 Apr 2015
Mr Drew Anthony Townsend Non-Executive Director 25 Jun 2014

MDC Management

Name Position
Alan Dworkin Chief Financial Officer,Company Secretary
Paul Vilner Director of Commercial Operations
Luis Vitetta Director of Medical Research
David Rutolo Director of Science

MDC Substantial Shareholders

Holding Name
55,755,555 (26.80%) Sean Michael Hall
21,855,556 (10.51%) Farjoy Pty Ltd
12,334,445 (5.93%) FIT Investments Pty Ltd
10,500,000 (5.05%) Realm Group Pty Ltd

MDC Calendar of Events

Date Event
21 February 2020 Report (Interim)
30 August 2019 Report (Annual)
30 August 2019 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.